These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Short-Term Dynamic Observation of the Color Change and Enhancement Effect of Polyethylenimine-Entrapped Gold Nanoparticles Used for Indirect Lymphography. Yang Y, Shi F, Zhou J, Shi X, Sha Y, Wu H. ORL J Otorhinolaryngol Relat Spec; 2016 May; 78(3):136-43. PubMed ID: 27234613 [Abstract] [Full Text] [Related]
49. [Interstitial T1-weighted MR lymphography with use of the dendritic contrast agent Gadomer-17 in pigs]. Staatz G, Nolte-Ernsting CC, Bücker A, Misselwitz B, Grosskortenhaus S, Pflüger D, Günther RW. Rofo; 2001 Dec; 173(12):1131-6. PubMed ID: 11740675 [Abstract] [Full Text] [Related]
50. [On dose dependence of side-effects by lipiodol ultrafluid in lymphography (author's transl)]. Koenig H. Radiol Diagn (Berl); 1977 Dec; 18(1):29-38. PubMed ID: 194272 [No Abstract] [Full Text] [Related]
51. Perfluorooctylbromide as a contrast agent for CT and sonography: preliminary clinical results. Behan M, O'Connell D, Mattrey RF, Carney DN. AJR Am J Roentgenol; 1993 Feb; 160(2):399-405. PubMed ID: 8424361 [Abstract] [Full Text] [Related]
52. [Indirect lymphography of the mediastinum and of the upper abdominal cavity in rabbits by means of tantalum oxide and tantalum carbide dust]. Sailer R, Stauch G. Z Exp Chir; 1973 Feb; 6(5):313-23. PubMed ID: 4792197 [No Abstract] [Full Text] [Related]
53. Diagnostic improvement of renal ultrasonography in humans after i.v. injection of perflenapent emulsion. Correas JM, Menassa L, Hélénon O, Méjean A, Boyer JC, Mamzer MF, Moreau JF. Acad Radiol; 1998 Apr; 5 Suppl 1():S185-8; discussion S199. PubMed ID: 9561077 [No Abstract] [Full Text] [Related]
54. Preclinical characterization of iopromide-carrying liposomes. Krause W, Sachse A, Wagner S, Kollenkirchen U, Rössling G. Invest Radiol; 1991 Nov; 26 Suppl 1():S172-4; discussion S175-6. PubMed ID: 1808120 [No Abstract] [Full Text] [Related]
55. Perflubron residua: 12 years following therapy. Servaes S, Epelman M. Pediatr Radiol; 2009 Apr; 39(4):393-5. PubMed ID: 19189093 [Abstract] [Full Text] [Related]
56. [A comparative study of Gd-DTPA and HSA-Gd-DTPA in magnetic resonance lymphography]. Wu YK, Fang TS, Chen DC, Liu GQ, Xu YK. Nan Fang Yi Ke Da Xue Xue Bao; 2007 Oct; 27(10):1597-600. PubMed ID: 17959548 [Abstract] [Full Text] [Related]
57. Studies on indirect lymphography in the dog. Sterns EE, Doris P. Can J Surg; 1967 Apr; 10(2):208-17. PubMed ID: 6066970 [No Abstract] [Full Text] [Related]
58. Effects of the long-term use of perfluoroperhydrophenanthrene on the retina. Batman C, Cekic O. Ophthalmic Surg Lasers; 1998 Feb; 29(2):144-6. PubMed ID: 9507258 [Abstract] [Full Text] [Related]
59. Effects of a prophylactic or therapeutic application of perflubron emulsion on myocardial ischaemia-reperfusion injury in rats. Rempf C, Standl T, Gottschalk A, Freitag M, Ritter A, Lang E, Tuszynski S, Burmeister MA. Eur J Anaesthesiol; 2008 Oct; 25(10):850-9. PubMed ID: 18538048 [Abstract] [Full Text] [Related]
60. [Method of indirect lymphography of the stomach]. Rizaev MN, Oster AN, Kaplun SS, Strusskiĭ LP, Kirilenko LB. Vestn Rentgenol Radiol; 1984 Oct; (2):24-7. PubMed ID: 6740900 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]